ESGE recommends that the evaluation of superficial gastrointestinal (GI) lesions should be
made by an experienced endoscopist, using high definition white-light and …

Background The risks of local recurrence and treatment-related morbidity need to be
balanced after local excision of early rectal cancer. The aim of this meta-analysis was to …

The implementation of bowel cancer screening programs has led to a rise in the incidence of
early rectal cancer. The combination of increased incidence and the growing interest in …

Background Overall survival from rectal cancer has almost doubled over the last 20 years.
Following recommendations in management guidelines plays some part in this, but the …

Background With the implementation of screening programs worldwide, diagnosis of early-
stage colorectal cancer steadily increased, including T1 cancer. Current T1 cancer treatment …

Background Rectal cancer is mainly cured by radical resection with neoadjuvant
chemoradiation or adjuvant chemotherapy. Pathological T1 lesions can be managed by …

A rise in the incidence of early rectal cancer consequent to bowel-screening programs
around the world and an increase in the incidence in young adults has led to a growing …

Aim Early rectal cancer can be managed effectively with local excision, which is now the
standard of care for many T1 lesions. However, the presence of unexpected adverse …

Background Local excision (LE) is a feasible treatment approach for rectal cancers in stage
pT1 and presents low pathological risk, whereas total mesorectal excision (TME) is a …

Objectives Radical surgery for rectal tumours has high morbidity. Local excision of such
tumours can be achieved without compromising oncologic safety. However tumours that are …